These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20560925)

  • 1. Frequencies of single-nucleotide polymorphisms of SLCO1A2, SLCO1B3 and SLCO2B1 genes in a Finnish population.
    Laitinen A; Niemi M
    Basic Clin Pharmacol Toxicol; 2011 Jan; 108(1):9-13. PubMed ID: 20560925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokinetics.
    Smith NF; Marsh S; Scott-Horton TJ; Hamada A; Mielke S; Mross K; Figg WD; Verweij J; McLeod HL; Sparreboom A
    Clin Pharmacol Ther; 2007 Jan; 81(1):76-82. PubMed ID: 17186002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between SLCO1B3 and ABCA3 polymorphisms and imatinib response in chronic myeloid leukemia patients.
    de Lima LT; Bueno CT; Vivona D; Hirata RD; Hirata MH; Hungria VT; Chiattone CS; Zanichelli MA; Chauffaille Mde L; Guerra-Shinohara EM
    Hematology; 2015 Apr; 20(3):137-42. PubMed ID: 25056761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes.
    Wright JL; Kwon EM; Ostrander EA; Montgomery RB; Lin DW; Vessella R; Stanford JL; Mostaghel EA
    Cancer Epidemiol Biomarkers Prev; 2011 Apr; 20(4):619-27. PubMed ID: 21266523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLCO2B1 genetic polymorphisms in a Korean population: pyrosequencing analyses and comprehensive comparison with other populations.
    Kim KA; Joo HJ; Lee HM; Park JY
    Mol Biol Rep; 2013 Jul; 40(7):4211-7. PubMed ID: 23666051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk.
    Justenhoven C; Schaeffeler E; Winter S; Baisch C; Hamann U; Harth V; Rabstein S; Spickenheuer A; Pesch B; Brüning T; Ko YD; Schwab M; Brauch H
    Breast Cancer Res Treat; 2011 Jan; 125(2):563-9. PubMed ID: 20635135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLCO2B1 c.935G>A single nucleotide polymorphism has no effect on the pharmacokinetics of montelukast and aliskiren.
    Tapaninen T; Karonen T; Backman JT; Neuvonen PJ; Niemi M
    Pharmacogenet Genomics; 2013 Jan; 23(1):19-24. PubMed ID: 23151832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians.
    Sortica Vde A; Ojopi EB; Genro JP; Callegari-Jacques S; Ribeiro-Dos-Santos A; de Moraes MO; Romano-Silva MA; Pena SD; Suarez-Kurtz G; Hutz MH
    Basic Clin Pharmacol Toxicol; 2012 May; 110(5):460-8. PubMed ID: 22136368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of polymorphisms of the SLCO2B1 transporter gene on the pharmacokinetics of montelukast in humans.
    Kim KA; Lee HM; Joo HJ; Park IB; Park JY
    J Clin Pharmacol; 2013 Nov; 53(11):1186-93. PubMed ID: 23970434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer.
    Yang M; Xie W; Mostaghel E; Nakabayashi M; Werner L; Sun T; Pomerantz M; Freedman M; Ross R; Regan M; Sharifi N; Figg WD; Balk S; Brown M; Taplin ME; Oh WK; Lee GS; Kantoff PW
    J Clin Oncol; 2011 Jun; 29(18):2565-73. PubMed ID: 21606417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLCO1B1, SLCO2B1, and SLCO1B3 polymorphisms and susceptibility to bladder cancer risk.
    Bui HT; Fujimoto N; Kubo T; Inatomi H; Matsumoto T
    Cancer Invest; 2014 Jul; 32(6):256-61. PubMed ID: 24762081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients.
    Chew SC; Sandanaraj E; Singh O; Chen X; Tan EH; Lim WT; Lee EJ; Chowbay B
    Br J Clin Pharmacol; 2012 Apr; 73(4):606-18. PubMed ID: 21995462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population.
    Pasanen MK; Backman JT; Neuvonen PJ; Niemi M
    Eur J Clin Pharmacol; 2006 Jun; 62(6):409-15. PubMed ID: 16758257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms.
    Hartkoorn RC; Kwan WS; Shallcross V; Chaikan A; Liptrott N; Egan D; Sora ES; James CE; Gibbons S; Bray PG; Back DJ; Khoo SH; Owen A
    Pharmacogenet Genomics; 2010 Feb; 20(2):112-20. PubMed ID: 20051929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure.
    Endo S; Fukahori A; Tokuhiro S; Shinagawa A; Walker J; Yoshihara K; Ishizuka H; Ieiri I; Sugiyama Y
    J Hum Genet; 2012 Aug; 57(8):531-44. PubMed ID: 22695893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extreme differences in SLCO1B3 functional polymorphisms in Roma and Hungarian populations.
    Nagy A; Szalai R; Magyari L; Bene J; Toth K; Melegh B
    Environ Toxicol Pharmacol; 2015 May; 39(3):1246-51. PubMed ID: 26005078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity.
    Schwarz UI; Meyer zu Schwabedissen HE; Tirona RG; Suzuki A; Leake BF; Mokrab Y; Mizuguchi K; Ho RH; Kim RB
    Pharmacogenet Genomics; 2011 Mar; 21(3):103-14. PubMed ID: 21278621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8).
    Letschert K; Keppler D; König J
    Pharmacogenetics; 2004 Jul; 14(7):441-52. PubMed ID: 15226676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of genetic variations of the SLCO1B1, SLCO1B3, and SLCO2B1 genes among five ethnic groups.
    Namgoong S; Cheong HS; Kim JO; Kim LH; Na HS; Koh IS; Chung MW; Shin HD
    Environ Toxicol Pharmacol; 2015 Nov; 40(3):692-7. PubMed ID: 26409184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients.
    Kunnari A; Ukkola O; Kesäniemi YA
    Diabet Med; 2005 May; 22(5):583-9. PubMed ID: 15842513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.